ViGeneron

Description: ViGeneron develops innovative gene therapies for retinal disorders using proprietary tech, partnering for broader applications.

Country: Germany

Based in: Starnberg

Founded: 2017

Funding Stage: Series A/B

Tags: ['Biotechnology', 'Health Care', 'Therapeutics']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.